PALOVAROTENE | PALOVAROTENE | ATC PALOVAROTENE
MUSCULO-SKELETAL SYSTEM RETINOID REDUCTION IN THE VOLUME OF NEW HETEROTOPIC OSSIFICATION TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP) RAR AGONIST | ORAL | Cmax 398 NANOMOLAR Tmax 3.5 HOUR VD 237 LITER PPB 98 PERCENT Cl 19.9 LITER / HOUR HT 8.7 HOUR | RETINOIC ACID RECEPTOR GAMMA (RAR GAMMA) | Retinoic acid receptor gamma UNIPROT P13631 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |